Inhaled preprandial human insulin

insulin · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inhaled preprandial human insulin, covering 2018-09-05 to 2018-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma [Phase 3]